Adaptive immune system in severe COVID-19 patients in the first week of illness: A pilot study / Fadime Ersoy Dursun [et al.]
Bibliogr.: p. 105-106. - Abstr. eng. - DOI: https://doi.org/10.1556/1886.2022.00022
In: European Journal of Microbiology and Immunology. - ISSN 2062-509X . - 2022. 12. évf. 4. sz., p. 100-106. : ill.
Introduction: The presentation of the course of COVID-19-related T-cell responses in the first week of the disease may be a more specific period for adaptive immune response assessment. This study aimed to clarify the relationship between changes in peripheral blood lymphocyte counts and death in patients with COVID-19 pneumonia. Methods: Thirty-three patients (14 females and 19 males) admitted for severe and desaturated COVID-19 pneumonia confirmed by polymerase chain reaction were included. Lymphocyte subsets and CD4+/CD8+ and CD16+/CD56+ rates were measured using flow cytometry from peripheral blood at admission and on the day of death or hospital discharge. Results: Twenty-eight patients survived and five died. On the day of admission, the CD4+ cell count was significantly higher and the saturation of O2 was significantly lower in the deceased patients compared to the survivors (P < 0.05). The CD16+/ CD56+ rate was significantly lower on the day of death in the deceased patients than in discharge day for the survivors (P 5 0.013). Conclusion: CD4+ lymphocyte percentages and O2 saturation in samples taken on the day of admission to the hospital and CD16+/CD56+ ratios taken at the time of discharge from the hospital were found to be associated with the mortality in patients with severe COVID-19. Kulcsszavak: COVID-19, CD4+ T-cells, CD8+ T-cells, lymphocyte subgroups